SEC Form D · filed July 10, 2017
Prellis Biologics, Inc
Offering
$2.1M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SAN FRANCISCO, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (7)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗